Impact of body mass index on mortality in heart failure patients

European Journal of Clinical Investigation

Volumn 44, Issue 12, 2014, Pages 1197-1205

  Takiguchi, Mai ^a   Yoshihisa, Akiomi ^a   Miura, Shunsuke ^a   Shimizu, Takeshi ^a   Nakamura, Yuichi ^a   Yamauchi, Hiroyuki ^a   Iwaya, Shoji ^a   Owada, Takashi ^a   Miyata, Makiko ^a   Abe, Satoshi ^a   Sato, Takamasa ^a   Suzuki, Satoshi ^a   Suzuki, Hitoshi ^a   Saitoh, Shu ichi ^a   Takeishi, Yasuchika ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adiponectin; Body mass index; Heart failure; Right heart function; Troponin T; Tumour necrosis factor

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA;

AGED; BODY MASS; COMPLICATION; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HEART FAILURE; HUMAN; KAPLAN MEIER METHOD; MALE; METABOLISM; MORTALITY; OBESITY; PROSPECTIVE STUDY; RISK FACTOR;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; TROPONIN T; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84912137334     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12354     Document Type: Article

References (43)

1. Shah R, Gayat E, Januzzi JL Jr, Sato N, Cohen-Solal A, Disomma S et al. Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol 2014;63:778-85.
2. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007;116:627-36.
3. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M, ADHERE Scientific Advisory Committee and Investigators et al. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108, 927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 2007;153:74-81.
4. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009;53:1925-32.
5. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG et al. Obesity and the risk of heart failure. N Engl J Med 2002;347:305-13.
6. Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV, Ventura HO. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail 2013;1:93-102.
7. Clark AL, Chyu J, Horwich TB. The obesity paradox in men versus women with systolic heart failure. Am J Cardiol 2012;110:77-82.
8. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008;156:13-22.
9. Carr JG, Stevenson LW, Walden JA, Heber D. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1989;63:709-13.
10. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997;349:1050-3.
11. Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003;361:1077-83.
12. Melenovsky V, Kotrc M, Borlaug BA, Marek T, Kovar J, Malek I et al. Relationships between right ventricular function, body composition, and prognosis in advanced heart failure. J Am Coll Cardiol 2013;62:1660-70.
13. Ghio S, Temporelli PL, Klersy C, Simioniuc A, Girardi B, Scelsi L et al. Prognostic relevance of a non-invasive evaluation of right ventricular function and pulmonary artery pressure in patients with chronic heart failure. Eur J Heart Fail 2013;15:408-14.
14. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997;96:526-34.
15. Wannamethee SG, Whincup PH, Lennon L, Sattar N. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med 2007;167:1510-7.
16. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005;112:1756-62.
17. Tsutamoto T, Tanaka T, Sakai H, Ishikawa C, Fujii M, Yamamoto T et al. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure. Eur Heart J 2007;28:1723-30.
18. Nakamura Y, Yoshihisa A, Takiguchi M, Shimizu T, Yamauchi H, Iwaya S et al. High-sensitivity cardiac troponin T predicts non-cardiac mortality in heart failure. Circ J 2014;78:890-5.
19. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-6.
20. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-54.
21. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-69.
22. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
23. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713; quiz 86-8.
24. Libera LD, Vescovo G. Muscle wastage in chronic heart failure, between apoptosis, catabolism and altered anabolism: a chimaeric view of inflammation? Curr Opin Clin Nutr Metab Care 2004;7:435-41.
25. Schulze PC, Gielen S, Schuler G, Hambrecht R. Chronic heart failure and skeletal muscle catabolism: effects of exercise training. Int J Cardiol 2002;85:141-9.
26. Berry C, Clark AL. Catabolism in chronic heart failure. Eur Heart J 2000;21:521-32.
27. Pittman JG, Cohen P. The pathogenesis of cardiac cachexia. N Engl J Med 1964;271:403-9 CONTD.
28. Anker SD, Ponikowski PP, Clark AL, Leyva F, Rauchhaus M, Kemp M et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999;20:683-93.
29. Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S et al. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 2007;50:1561-9.
30. Abe S, Yoshihisa A, Takiguchi M, Shimizu T, Nakamura Y, Yamauchi H et al. Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure. PLoS One 2014;9:e100618.
31. Poehlman ET, Scheffers J, Gottlieb SS, Fisher ML, Vaitekevicius P. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med 1994;121:860-2.
32. Anker SD, Coats AJ. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 1999;115:836-47.
33. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001;38:789-95.
34. McEntegart MB, Awede B, Petrie MC, Sattar N, Dunn FG, MacFarlane NG et al. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J 2007;28:829-35.
35. Florea VG, Henein MY, Rauchhaus M, Koloczek V, Sharma R, Doehner W et al. The cardiac component of cardiac cachexia. Am Heart J 2002;144:45-50.
36. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-5.
37. Ai M, Otokozawa S, Asztalos BF, White CC, Cupples LA, Nakajima K et al. Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study. Atherosclerosis 2011;217:543-8.
38. Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A, Zethelius B. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 2007;92:571-6.
39. Efstathiou SP, Tsioulos DI, Tsiakou AG, Gratsias YE, Pefanis AV, Mountokalakis TD. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 2005;36:1915-9.
40. Wilson SR, Sabatine MS, Wiviott SD, Ray KK, De Lemos JA, Zhou S et al. Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22). Am Heart J 2011;161:1147-55.e1.
41. Szwejkowski BR, Elder DH, Shearer F, Jack D, Choy AM, Pringle SD et al. Pulmonary hypertension predicts all-cause mortality in patients with heart failure: a retrospective cohort study. Eur J Heart Fail 2012;14:162-7.
42. White HD. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol 2011;57:2406-8.
43. Kelley WE, Januzzi JL, Christenson RH. Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem 2009;55:2098-112.